SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-039351
Filing Date
2023-02-14
Accepted
2023-02-14 17:07:13
Documents
13
Period of Report
2023-02-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d464805d8k.htm   iXBRL 8-K 34024
2 EX-3.1 d464805dex31.htm EX-3.1 9080
  Complete submission text file 0001193125-23-039351.txt   175248

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20230208.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20230208_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20230208_pre.xml EX-101.PRE 11713
7 EXTRACTED XBRL INSTANCE DOCUMENT d464805d8k_htm.xml XML 3645
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36577 | Film No.: 23631349
SIC: 2834 Pharmaceutical Preparations